The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Macopharma is one of the key players in the medical device industry for blood transfusion, solution bags and biotherapy.
Their growth has always been driven by major innovations. These innovations are the result of substantial investments in research and development, as well as cooperation with customers and partners: blood centres, research laboratories, hospitals…
For each of these 3 fields, Macopharma offers a range of products and services for each step of the processes.
With 2300 employees, 4 plants (2 in France, 1 in Poland and 1 in Tunisia) and worldwide presence in nearly 100 countries, Macopharma aims at offering innovative solutions and quality products to optimise therapeutic practices and make them safer.